Angiotensin-I-converting enzyme inhibitory activities of gastric and pancreatic proteinase digests of whey proteins

Margaret M. Mullally, Hans Meisel, Richard J. Fitzgerald

Research output: Contribution to journalArticlepeer-review

Abstract

Enzymatic hydrolysates of bovine β-lactoglobulin (β-Lg), α-lactalbumin (α-La) and whey protein concentrate (WPC) were analysed for their angiotensin-I-converting enzyme (ACE) inhibitory activity. The unhydrolysed substrates gave very low ACE inhibitory indices, i.e. < 10%. Hydrolysis of the whey proteins by pepsin, trypsin, chymotrypsin and the commercially available enzyme preparations, Corolase PP and PTN 3.0S, resulted in high ACE inhibition indices, i.e. 73-90%. Hydrolysates generated with elastase displayed relatively low ACE inhibitory activity. The order of trypsin and pepsin addition during the hydrolysis of α-La and β-Lg did not appear to affect the ACE inhibitory activity of the resulting hydrolysate. Preliminary studies indicated that ultrafiltration through 3 and 1 kDa molecular mass cut-off membranes may be exploited to enrich for ACE inhibitory peptides. The ACE IC50 inhibition values obtained for ultrafiltered tryptic digests of β-Lg and WPC ranged from 130-201 mg L-1. The potential application of whey protein hydrolysates as nutraceuticals in the prevention of hypertension is discussed.

Original languageEnglish
Pages (from-to)299-303
Number of pages5
JournalInternational Dairy Journal
Volume7
Issue number5
DOIs
Publication statusPublished - May 1997

Keywords

  • ACE inhibition
  • Bioactive peptides
  • Nutraceutical
  • Whey protein hydrolysates

Fingerprint

Dive into the research topics of 'Angiotensin-I-converting enzyme inhibitory activities of gastric and pancreatic proteinase digests of whey proteins'. Together they form a unique fingerprint.

Cite this